Opinion: STAT readers debate blue zones, open-access publishing fees, and more

STAT's First Opinion platform is soliciting Letters to the Editor to foster discussion on life sciences topics, as evidenced by recent submissions debating "blue zones" and open-access publishing fees. The platform aims to feature provocative articles from industry insiders, healthcare professionals, and researchers. Selected letters are published to encourage robust, good-faith dialogue on the issues presented in the First Opinion essays. Interested parties can submit their letters via a dedicated form found at the end of any First Opinion essay.